A new advance may make it possible to use off-the-shelf CAR T cells provided by healthy donors. The new approach studied in mice equipped CAR T cells with the viral protein Nef.

Researchers found that bioengineered CAR-T cells when mixed with other immune cells can "donate" proteins, suggesting ...

CAR T cell therapy is one of the most promising new cancer treatments to emerge in recent years. It involves removing a ...

这项发表于 Cell 的研究表明，YTHDF2 在 B 细胞恶性肿瘤的起始、进展和免疫逃避中发挥着关键的致癌作用。YTHDF2 的小分子抑制剂 CCI-38 与 CD19-CAR-T 细胞 ...

"Next, we are studying how to dynamically adapt these CAR T cells at the synapse level to make them more effective." "Tumors are very sophisticated. We need to adapt our tools to the biology of ...

Therapeutic CAR-NK cells produced from iPSCs address some of the key limitations of CAR-T cell therapies and could make cellular immunotherapy more accessible globally." ...

“Next, we are studying how to dynamically adapt these CAR T cells at the synapse level to make them more effective.” “Tumors are very sophisticated. We need to adapt our tools to the biology of the ...

Therapeutic CAR-NK cells produced from iPSCs address some of the key limitations of CAR-T cell therapies and could make cellular immunotherapy more accessible globally." Off-the-shelf immunotherapy ...